Executive Moves is an occasional feature on ROI-NJ.com describing some of the important personnel changes in the New Jersey business community. Reports are based on news releases, edited for content, clarity and style.
Charles Heydt, Dresdner Robin
New Jersey-based land-use consultancy Dresdner Robin has announced that Charles Heydt will become the firm’s director of planning. Heydt, who has more than 10 years of experience in land development projects, formerly served as assistant director of planning. He is qualified as an expert professional planner and has provided planning testimony for over 100 local land-use boards.
In the role, Heydt will be tasked with the oversight of all planning services and the direction of the department. Internally, he will also work to develop staff skills and technical understanding of complex zoning issues. As director of planning, he will also look to develop new services and opportunities for the firm, whose geographic footprint is significant across the tri-state area.
“We’re thrilled to announce that Charles has been named Dresdner Robin’s director of planning. He is a skilled planner with a unique vision and ability to bring clients’ land-use goals to fruition,” said Fred Worstell, president of Dresdner Robin. “We look forward to the dynamic work that lies ahead for Charles and our firm’s Planning Division.”
Cindy Jacques, LeadingAge New Jersey & Delaware
United Methodist Communities, a New Jersey-based senior living and care organization, is pleased to announce the appointment of Cindy Jacques, vice president of housing and community initiatives, to a three-year term on the board of LeadingAge New Jersey & Delaware.
LeadingAge New Jersey & Delaware is the statewide association of not-for-profit senior care organizations and is dedicated to advancing quality aging services in New Jersey and Delaware through advocacy, education and fellowship.
As the board liaison to the association’s Housing Managers Roundtable, Cindy will support their goals to advance policies, promote practices and conduct research that supports, enables, and empowers people to live fully as they age.
Dr. Gabriel Kaplan, RWJBarnabas Health
RWJBarnabas Health announced that Dr. Gabriel Kaplan, board-certified adult and child/adolescent psychiatrist and chief medical officer of the Behavioral Health and Addictions Service Line, has recently been advanced to clinical professor of psychiatry at Rutgers New Jersey Medical School.
RWJBarnabas Health and Rutgers New Jersey Medical School will continue to benefit from Kaplan’s connection with the New Jersey Medical School, as he contributes to the partnership and operational excellence across both organizations. Kaplan will continue to focus on the delivery of high-quality patient care, and the clinical training of tomorrow’s health care workforce. His role creates further opportunities to more effectively bridge the worlds of treatment and clinical education to improve access to care and reduce health disparities in New Jersey.
“Dr. Kaplan’s clinical and academic experience provides leadership and enhances the quality and growth of the Behavioral Health and Addictions Service Line across RWJBarnabas Health, and will reinforce synergies with Rutgers New Jersey Medical School and the health care system” said Frank A. Ghinassi, senior vice president of Behavioral Health and Addictions Service Line, RWJBarnabas Health, and CEO and president of Rutgers University Behavioral Health Care.
David Busch, EmpiRx Health
EmpiRx Health, the industry’s only value-based pharmacy benefit manager, announced it has appointed David Busch as chief growth officer. Busch will oversee strategic business development and build on EmpiRx Health’s growing momentum as plan sponsors seek sustainable clinically-based health benefits.
Busch brings 25 years of experience as a national growth executive and consultant focused on developing go-to-market strategies and driving transformation across health care, behavioral health and payer organizations. Additionally, Busch has successfully optimized sales operations serving more than 22 million members.
(Not pictured.)
Celularity Inc.
Celularity Inc., a clinical-stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced the addition of two senior executives to its distinguished leadership team.
Dr. Gregory Berk joins Celularity as chief medical officer, with overall responsibility for the company’s clinical and clinical development programs in oncology, infectious and degenerative disease. He brings over 30 years of experience in medicine, industry, and academia, with extensive expertise in oncology drug development from the early clinical phase to post commercialization. Chi Li joins Celularity as senior vice president, chief regulatory officer, with responsibility for regulatory affairs as the company advances multiple programs into clinical development. He brings nearly 20 years of experience leading drug and biologic product development and has played an instrumental role in driving the development and approvals of several drugs and biologic products globally and/or in the U.S.
(Not pictured.)
Carolina Gutierrez, Alfred Sanzari Enterprises
Alfred Sanzari Enterprises, a preeminent family-owned and operated commercial and residential real estate firm, announced that Carolina Gutierrez has been promoted to manager – leasing and marketing.
Since joining Alfred Sanzari Enterprises in 2019 as a property management analyst, Gutierrez has been a key contributor in several departmental and tenant management initiatives. Building upon seven years of tenant management and operational experience prior to joining Alfred Sanzari Enterprises, Gutierrez quickly excelled in her role at the firm, providing Alfred Sanzari Enterprises with invaluable insight into its portfolio with a particular focus on identifying trends in utility usage. Additionally, Gutierrez developed an in-depth understanding of the firm’s iconic flagship property Glenpointe, building a strong rapport with the campus’ 70-plus tenants and gaining a comprehensive understanding of their unique needs. In her new role, Gutierrez will expand upon and hone her tenant liaison skills as well as spearhead a number of marketing initiatives to help drive leasing activity and enhance tenant retention across Sanzari’s commercial portfolio, with an emphasis on Glenpointe.
(Not pictured.)
Douglas Losordo, KBP Biosciences
KBP Biosciences, a clinical-stage biotechnology company dedicated to research, development, and commercialization of innovative medicines for the global market, announced the appointment of Dr. Douglas W. Losordo to the newly created position of chief medical officer.
Losordo, who will report directly to CEO Thijs Spoor, will lead all global clinical development and regulatory initiatives for the company. Losordo is an accomplished physician and health care executive with more than 20 years of academic research, clinical and corporate experience.
Caladrius Biosciences Inc., a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, announced that industry veteran Dr. Robert Honigberg has been retained to assume the role of interim CMO, replacing Losordo.
(Not pictured.)
Gennady Spivak, Clear Thinking Group LLC
Clear Thinking Group LLC announced that Gennady Spivak has joined the firm as a managing director. Spivak is an accomplished professional with a proven record in bankruptcy and insolvency, financial analysis, forensic accounting, fraud investigation, litigation support and wind down management.
Prior to joining Clear Thinking Group, Spivak was a senior manager in the Corporate Recovery & Litigation Services practice of a major accounting firm, where he specialized in the fields of bankruptcy and insolvency, creditors’ rights and litigation support. Spivak has worked as a financial adviser to debtors, unsecured creditors’ committees, trustees, receivers, plan administrators and other parties-in-interest in numerous bankruptcy proceedings. His experience includes liquidation and winddown management, claims administration, fraudulent conveyance and preference litigation and defense work.
(Not pictured.)
Student/Partner Alliance
The board of Student/Partner Alliance, a Summit based nonprofit, which supports low-income, urban high schools in the greater Newark and Jersey City areas, is pleased to announce the addition of two new board members, Anoop George and Jaime de Leon.
George has served as a mentor for S/PA since 2014; he is passionate about mentoring students and understands the value it brings to harness their full potential. He is a senior client partner with Toptal, a professional services company supporting enterprises in the strategy, business, and technology space. De Leon is the director of admissions and public relations at Hudson Catholic High School in Jersey City. He has been working in the admissions field for over 20 years, both at the high school and college level.
(Not pictured.)
